A detailed history of Dunhill Financial, LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Dunhill Financial, LLC holds 328 shares of BSX stock, worth $29,736. This represents 0.01% of its overall portfolio holdings.

Number of Shares
328
Previous 176 86.36%
Holding current value
$29,736
Previous $13.5 Million 103.14%
% of portfolio
0.01%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$72.96 - $84.0 $11,089 - $12,768
152 Added 86.36%
328 $27.5 Million
Q2 2024

Aug 09, 2024

BUY
$67.33 - $77.71 $1,885 - $2,175
28 Added 18.92%
176 $13.5 Million
Q1 2024

May 13, 2024

BUY
$57.6 - $68.62 $921 - $1,097
16 Added 12.12%
148 $10.1 Million
Q4 2023

Feb 12, 2024

BUY
$48.64 - $57.81 $6,420 - $7,630
132 New
132 $7.61 Million

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $130B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Dunhill Financial, LLC Portfolio

Follow Dunhill Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dunhill Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dunhill Financial, LLC with notifications on news.